Live Quote · NASDAQMCRBHealthcare· Biotechnology

Seres Therapeutics, Inc.

$1.24▼ 6.77%($-0.09)
MKT CAP $12.64MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
60
Valuation
35
Profitability
60
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MCRB research report →

Analyst Price Target
$12.00+867.7% vs. today

Range $12 – $12

Analyst RatingBuy
11 Buy3 Hold4 Sell

Price Chart

-94.29% · this period
$21.70$11.47$1.24Nov 20May 26Nov 20
52-Week Range0% of range
Low
$1.20
Current
$1.24
High
$20.30